Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.

MLA

Musa, Ahmed M., et al. “Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.” Clinical Infectious Diseases, vol. 76, no. 3, Feb. 2023, pp. e1177–85. EBSCOhost, https://doi.org/10.1093/cid/ciac643.

APA

Musa, A. M., Mbui, J., Mohammed, R., Olobo, J., Ritmeijer, K., Alcoba, G., Ouattara, G. M., Egondi, T., Nakanwagi, P., Omollo, T., Wasunna, M., Verrest, L., Dorlo, T. P. C., Younis, B. M., Nour, A., Elmukashfi, E. T. A., Haroun, A. I. O., Khalil, E. A. G., Njenga, S., & Fikre, H. (2023). Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial. Clinical Infectious Diseases, 76(3), e1177–e1185. https://doi.org/10.1093/cid/ciac643

Chicago

Musa, Ahmed M, Jane Mbui, Rezika Mohammed, Joseph Olobo, Koert Ritmeijer, Gabriel Alcoba, Gina Muthoni Ouattara, et al. 2023. “Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.” Clinical Infectious Diseases 76 (3): e1177–85. doi:10.1093/cid/ciac643.